Submit Manuscript  

Article Details

Rhenium-188 and Copper-67 Radiopharmaceuticals for the Treatment of Bladder Cancer

[ Vol. 4 , Issue. 1 ]


M. Frier   Pages 61 - 68 ( 8 )


The favourable nuclear properties of copper-67 and rhenium-188 for therapeutic application are described, together with methods for the chemical synthesis of a number of derivatives. Survival from invasive bladder cancer has changed little over the past 20 years. The intravesicular administration of Cu-67 or Re-188 radiopharmaceuticals in the treatment of bladder cancer offers some promise for improvement in this situation.


Rhenium-188, Copper-67, Bladder, Cancer, Radioimmunotherapy


Radiopharmacy Unit,Queens Medical Centre, Nottingham, UK

Read Full-Text article